Get the Stockscreener App
9.30
1.09%
0.10
After Hours:
9.30
Pavmed Inc stock is traded at $9.30, with a volume of 10,412.
It is up +1.09% in the last 24 hours and down -10.40% over the past month.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.
See More
Previous Close:
$9.20
Open:
$9.13
24h Volume:
10,412
Relative Volume:
0.01
Market Cap:
$8.57M
Revenue:
$29,000
Net Income/Loss:
$1.43M
P/E Ratio:
-0.3452
EPS:
-26.9407
Net Cash Flow:
$-3.58M
1W Performance:
-11.00%
1M Performance:
-10.40%
6M Performance:
-27.92%
1Y Performance:
-59.18%
1-Day Range:
$9.13
$9.79
1-Week Range:
$9.08
$10.22
52-Week Range:
$6.00
$28.44
Pavmed Inc Stock (PAVM) Company Profile
Name
Pavmed Inc
Sector
Industry
Phone
(212) 949-4319
Address
360 MADISON AVENUE, NEW YORK, NY
Compare PAVM vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PAVM
Pavmed Inc
|
9.30 | 8.48M | 29,000 | 1.43M | -3.58M | -26.94 |
ABT
Abbott Laboratories
|
104.83 | 180.82B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
327.65 | 125.72B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.89 | 111.16B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
69.78 | 101.28B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
82.67 | 47.45B | 6.07B | 1.06B | 1.34B | 1.8063 |
Pavmed Inc Stock (PAVM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-30-21 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-05-20 | Initiated | Ascendiant Capital Markets | Buy |
| Jun-28-18 | Initiated | Maxim Group | Buy |
Pavmed Inc Stock (PAVM) Latest News
Lucid Diagnostics Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
PAVmed Q4 2025 earnings preview - MSN
If You Invested $1,000 in Lucid Diagnostics Inc. (LUCD) - Stock Titan
Aug Shorts: Can PAVmed Inc expand into new markets2026 Fundamental Recap & Stock Portfolio Risk Management - baoquankhu1.vn
PAVM.O Technical Analysis & Stock Price Forecast - Intellectia AI
Levels Update: Can PAVmed Inc maintain its current growth rate2026 Major Catalysts & AI Driven Price Predictions - baoquankhu1.vn
PAVmed: Fundamental Analysis and Financial Ratings | 1P50 | US70387R4039 - marketscreener.com
PAVMED announces 1-for-30 reverse stock split - MSN
PAVM Price History for Pavmed Stock - Barchart.com
PAVmed Inc.: Fundamental Analysis and Financial Ratings | 1P50 | US70387R5028 - marketscreener.com
Resistance Check: Is PAVmed Inc stock a value trap2026 Key Lessons & Precise Buy Zone Tips - baoquankhu1.vn
Aug Opening: Is PAVmed Inc a stock for growth or value investorsDollar Strength & AI Driven Price Predictions - baoquankhu1.vn
Short Covering: Whats next for PAVmed Inc stockEarnings Overview Summary & Free Real-Time Volume Trigger Notifications - baoquankhu1.vn
PAVmed to Hold Q4 and Full Year 2025 Business Update Call on March 30, 2026 - National Today
Price Action: Does PAVmed Inc have pricing power2026 Decliners & Entry Point Confirmation Alerts - baoquankhu1.vn
PAVmed executives to outline 2025 strategy, Q4 results on March 30 call - Stock Titan
LUCD SEC FilingsLucid Diagnostics Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Lucid Diagnostics to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 26, 2026 - Sahm
Analyst Upgrade: Is PAVmed Inc stock a value trap2026 Intraday Action & Safe Entry Trade Reports - baoquankhu1.vn
Stock Recap: Can PAVmed Inc expand into new markets2026 Earnings Surprises & Weekly Watchlist for Consistent Profits - baoquankhu1.vn
Lucid Diagnostics CEO to detail growth strategy in March 26 call - Stock Titan
PAVM.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
PAVM Should I Buy - Intellectia AI
Panic Selling: Can PAVmed Inc maintain its current growth rateQuarterly Market Summary & Weekly Consistent Profit Watchlists - baoquankhu1.vn
Earnings Risk: Whats next for PAVmed Inc stockJuly 2025 Catalysts & Safe Capital Preservation Plans - baoquankhu1.vn
PAVM Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
PAVM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
PAVmed (NASDAQ: PAVM) seeks approval for major share and equity plan changes - Stock Titan
Levels Update: Is PAVmed Inc stock a value trapInflation Watch & Step-by-Step Trade Execution Guides - baoquankhu1.vn
Volatility Watch: Is NVR Inc stock trending bullish2025 Price Momentum & Weekly High Momentum Picks - baoquankhu1.vn
Lucid Diagnostics Provides Business Update and Reports Third Quarter 2025 Financial Results - Intellectia AI
Earnings Recap: What is PAVmed Incs market position2025 Investor Takeaways & Community Shared Stock Ideas - baoquankhu1.vn
Ayrton Capital LLC Reduces Stake in Traws Pharma Inc - GuruFocus
Is PAVmed Inc. stock a value trapJuly 2025 Fed Impact & Verified Technical Trade Signals - mfd.ru
Is PAVmed Inc. stock a top performer YTDJuly 2025 Weekly Recap & Stepwise Swing Trade Plans - mfd.ru
Can PAVmed Inc. sustain its profitabilityTrade Risk Assessment & Stepwise Swing Trade Plans - mfd.ru
Signal Recap: Will PAVmed Inc stock hit new highs in YEARInsider Buying & Real-Time Volume Triggers - baoquankhu1.vn
Aug Sectors: Is PAVmed Inc a potential multi baggerWeekly Gains Report & Daily Risk Controlled Trade Plans - baoquankhu1.vn
PAVmed Restructures Capital With New Preferred Financing - The Globe and Mail
Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard® - Eastern Progress
PAVmed raises $45 million, restructures capital to eliminate convertible debt - Investing.com
PAVmed raises $45 million, restructures capital to eliminate convertible debt By Investing.com - Investing.com India
PAVmed Signs Multiple Financing Agreements - TradingView
PAVmed Closes Preferred Stock and Senior Secured Note Financings, Eliminating All Previously Outstanding Convertible Securities - PR Newswire
PAVmed Inc. announced that it expects to receive $30 million in funding - marketscreener.com
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Lucid Diagnostics inks deal with VA to use esophageal cancer screen - Crain's New York Business
Technical Analysis: Is PAVmed Inc a stock for growth or value investorsMarket Performance Recap & High Return Trade Opportunity Guides - baoquankhu1.vn
What makes PAVmed Inc. stock attractive todayM&A Rumor & Consistent Profit Trading Strategies - mfd.ru
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025 - Quantisnow
Lucid Diagnostics: Green Flags, But Dilution And Friction Keep Me Neutral (LUCD) - Seeking Alpha
Pavmed Inc Stock (PAVM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):